What this study is
30 Veterans who are full-time wheelchair users will use personalized modular cushions for two weeks each. Personalized cushions will be created using a cushion fitting process the investigators have already developed and tested. Microenvironmental conditions will be monitored during use. A cost analysis will ensure the customized modular cushion applies value-driven principles. User satisfaction will be measured along with the effects on daily function, skin status and seated tissue health.
What's being tested
- Use of GEL BALL FITTED MODULAR CUSHION
Intervention · DEVICE
DAILY COMMUNITY USE OF GEL BALL FITTED MODULAR CUSHION for 2 weeks
- Use of SQUISHINS FITTED MODULAR CUSHION
Intervention · DEVICE
DAILY COMMUNITY USE OF SQUISHINS FITTED MODULAR CUSHION for 2 weeks
Study details
- Official title
- Development of Advanced Personalized Modular Pressure Relief Seating Cushion Systems: Testing and User Evaluation
- Sponsor
- VA Office of Research and Development
- Conditions
- Mobility Impairment
- Enrolling
- 30 people
- Starts
- 2027-08-23
- Est. completion
- 2029-09-30
- Design
- Open-label, randomized, crossover
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 18 Years and overSex ALLHealthy volunteers Not acceptedYou may qualify if
- Veterans with mobility impairments requiring full time use of a power or manual wheelchair who are served through the LSCDVAMC Wheeled Mobility Clinic.
You can't join if
- Pregnancy
- Inability to remain seated in the wheelchair for more than 4 hours/day
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (1)
1 openLouis Stokes VA Medical Center, Cleveland, OH
Cleveland, Ohio, United States
- Kath M Bogie, PhD · Contact(204) 778-3083Katherine.Bogie@va.gov
- Kath M. Bogie, PhD · Principal investigator
Study team
Sponsor
VA Office of Research and Development
Study ID A2434-R
Principal investigator
Kath M. Bogie, PhD
Louis Stokes VA Medical Center, Cleveland, OH
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.